These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32629594)

  • 1. [Clinical features and outcomes in relapsing and monophasic patients with anti-leucine-rich glioma-inactivated 1 encephalitis].
    Li JM; Ma XR; Peng T; Li JH; Lu H
    Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1947-1951. PubMed ID: 32629594
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical features of 28 cases of anti
    Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis.
    Li J; Li H; Wang Y; Zhao X; Wang S; Li L
    Front Immunol; 2022; 13():1071219. PubMed ID: 36685530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
    Huang X; Fan C; Gao L; Li L; Ye J; Shen H
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort.
    Li HY; Qiao S; Cui CS; Feng F; Liu XW; Yang XD
    J Clin Neurosci; 2022 Jul; 101():137-143. PubMed ID: 35597061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
    Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
    Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the functional outcomes of anti-LGI1 encephalitis using a random forest model.
    Li G; Liu X; Wang M; Yu T; Ren J; Wang Q
    Acta Neurol Scand; 2022 Aug; 146(2):137-143. PubMed ID: 35373330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-LGI1 encephalitis recurring 3 years after the first episode: a case report.
    Fujita H; Shioda M; Suzuki K
    BMC Neurol; 2022 Apr; 22(1):148. PubMed ID: 35448972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
    Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma-inactivated protein 1 encephalitis: a prospective observational cohort study.
    Liu M; Xu X; Fan S; Ren H; Zhao Y; Guan H
    Neurol Sci; 2024 Jan; 45(1):253-260. PubMed ID: 37580515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
    Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
    Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin and significance of leucine-rich glioma-inactivated 1 antibodies in cerebrospinal fluid.
    Zhang F; Zhou H; Yi Y; Li N; Liu M; Shen H; Guo Y; Wang J
    Neurol Sci; 2024 Sep; 45(9):4493-4500. PubMed ID: 38551680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
    Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
    Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.
    Murayama A; Sugaya K; Hara M; Kawazoe T; Tobisawa S; Nakajima H; Takahashi K
    Intern Med; 2023 Jun; 62(11):1659-1663. PubMed ID: 36223927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
    Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
    [No Abstract]   [Full Text] [Related]  

  • 16. What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
    Li C; Cai HB; Zhao X; Xi XC; Zhou Q; Luo HY; Tang ZP; Kang HC; Kirsch HE
    Eur Neurol; 2022; 85(6):437-445. PubMed ID: 35896086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of patients with anti-leucine-rich glioma inactivated-1 protein associated encephalitis: a Chinese case series.
    Yang X; Li AN; Zhao XH; Liu XW; Wang SJ
    Int J Neurosci; 2019 Aug; 129(8):754-761. PubMed ID: 30621547
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
    Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
    BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing clinical features, severity and prognosis of autoimmune encephalitis and with and without oligoclonal bands.
    Xue H; Guo X; Jiang Y; Qin L; Wang X; Xu J; Zuo S; Liu Q; Li W
    Front Neurol; 2023; 14():1281276. PubMed ID: 38249729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics, long-term functional outcomes and relapse of anti-LGI1/Caspr2 encephalitis: a prospective cohort study in Western China.
    Guo K; Liu X; Lin J; Gong X; Li A; Liu Y; Zhou D; Hong Z
    Ther Adv Neurol Disord; 2022; 15():17562864211073203. PubMed ID: 35069805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.